SCANDONEST 2% WITH LEVONORDEFRIN
NOVOCOL PHARMACEUTICAL OF CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is SCANDONEST 2% WITH LEVONORDEFRIN discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that SCANDONEST 2% WITH LEVONORDEFRIN 0.05MG 20MG has been permanently discontinued (last updated September 15, 2023). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is SCANDONEST 2% WITH LEVONORDEFRIN not available?
The reason the manufacturer reported: Raw material availability.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02313863
Strength
0.05MG 20MG
Dosage Form
SOLUTION
Route
BLOCK/INFILTRATION
Active Ingredient
CORBADRINE MEPIVACAINE HYDROCHLORIDE
Tier
Unrated
Last Updated
2023-09-15
Reason for Shortage
Raw material availability
Other Products from NOVOCOL PHARMACEUTICAL OF CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.